News from the healthcare data industry
Company announces multi-year strategic partnership with AstraZeneca to accelerate early breast cancer evidence development and research August 21, 2023 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–PicnicHealth, a patient-centered health...
Dec 09, 2022 | staff reporterSave for later NEW YORK — Guardant Health said on Thursday that it has signed an agreement to develop its Guardant360 CDx blood-based liquid biopsy assay as...
– Using Invitae’s Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a rare cancer to drive further research – – Real-world insights...
The companies will reportedly focus on exploring real-world evidence and conducting clinical trials through G42 Healthcare’s Contract Research Organisation, IROS.By Rachel McArthurDecember 24, 202108:37 AM Credit: iStock AstraZeneca has teamed...
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year, strategic collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) in which the two companies will work together to gather...